SpotSee recently launched TempMonitor, a single-use temperature indicator designed for patients who rely on insulin and other medications.
TempMonitor helps distributors and patients know that their refrigerated medications have remained within the manufacturers’ recommended temperature ranges, the company reported. The single-use indicators use SpotSee’s WarmMark technology to provide visual evidence if a medication is exposed to unacceptable temperature levels, signaling possible compromise of product quality.
“At SpotSee we are focused on building solutions that span from pallet to patient and SpotSee’s TempMonitor addresses the critical need for monitoring the storage of patient’s temperature-sensitive medication, including insulin and [Glucagon-like, peptide-1 medications],” Tony Fonk, SpotSee president and CEO, said in a news release.
“We recognize the challenges faced by patients and their families who depend on these types of medications every day, all around the world. By using TempMonitor, patients can gain peace of mind knowing that their medications are stored and transported within the recommended temperature range.”
TempMonitors are discreet and easy to carry, making them a convenient solution, the company maintained. Packaged in units of 10, the monitors are available for purchase in the U.S. and Canada.
Visit spotsee.io/tempmonitor for more information or to order the product.
